Apogee Therapeutics Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, Apogee Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $119.69. The average 1-year stock price forecast is 47.06% higher than the current stock price, while the lowest is $82 (+0.75%) and the highest is $160 (+96.58%).

Price Target: $119.69 (+47.06%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$82	$119.69	$120	$160
Change	+0.75%	+47.06%	+47.44%	+96.58%

Analyst Ratings

The average analyst rating for Apogee Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	6	6	6	7	7	8
Buy	3	2	2	3	3	3
Hold	0	2	2	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	10	10	13	13	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Qize Ding Rothschild & Co	Rothschild & Co	Strong Buy Initiates $140	Strong Buy	Initiates	$140	+72.01%	May 1, 2026
Joseph Catanzaro Mizuho	Mizuho	Buy Maintains $105 → $110	Buy	Maintains	$105 → $110	+35.15%	Mar 30, 2026
Geoff Meacham Citigroup	Citigroup	Strong Buy Maintains $95 → $125	Strong Buy	Maintains	$95 → $125	+53.58%	Mar 24, 2026
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $89 → $130	Strong Buy	Maintains	$89 → $130	+59.72%	Mar 24, 2026
Seamus Fernandez Guggenheim	Guggenheim	Strong Buy Maintains $130 → $160	Strong Buy	Maintains	$130 → $160	+96.58%	Mar 24, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-4.60

from -4.22

EPS Next Year

-5.52

from -4.60

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028
Revenue	-	-	-	-	-	-	5.64M
Revenue Growth	-	-	-	-	-	-	-
EPS	-17.63	-3.36	-3.30	-4.22	-4.60	-5.52	-6.81
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	20	20	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-3.97	-4.47
Avg	-4.60	-5.52
Low	-5.26	-10.11

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.